ArticleFrontiers in psychology2025
Brazilian version of the Brief Screener for Substance and Behavioral Addiction.
Article in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Excessive and compulsive behaviors, including substance and behavioral addictions, represent a growing global concern. In Brazil, the increasing prevalence of these behaviors underscores the need for effective screening tools to identify individuals at risk. The Brief Screener for Substance and Behavioral Addiction (SSBA) has been recognized internationally for its utility in both clinical assessment and public health surveillance. This study aimed to adapt the SSBA for use in Brazil, with potential applications in other Portuguese-speaking countries. Methods: The adaptation process followed international guidelines for cross-cultural adaptation of psychometric instruments. It included forward translation into Portuguese, back-translation into English, and expert committee review to ensure semantic and conceptual equivalence. A pilot study was conducted to assess clarity and relevance. Subsequently, the Brazilian version of the SSBA was administered to a sample of 450 individuals, comprising both clinical and non-clinical populations. Psychometric analyses evaluated the instrument's reliability, validity, and factorial structure. Results: The Brazilian version of the SSBA demonstrated good internal consistency and satisfactory construct validity across subscales. Confirmatory factor analysis supported the original structure of the instrument, and no major linguistic or cultural adaptations were required. The screener showed strong discriminative power between clinical and non-clinical participants, indicating its effectiveness for identifying individuals at risk for addiction-related disorders. Discussion: The adapted SSBA is a reliable and valid tool for the Brazilian context and may be extended to other Lusophone countries. It provides a brief yet comprehensive screening method suitable for various settings, including clinical practice, research, and community health. The instrument is particularly valuable for health professionals working in addiction prevention, diagnosis, and treatment, supporting early identification and intervention efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.